A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer
A Phase Ⅲ Trial to Compare Efficacy and Safety of Definitive Chemoradiation VS Neoadjuvant Chemoradiation Plus Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Treatment for Locally Advanced Esophageal Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
This PHASE3 trial investigates Stage II Esophageal Cancer and Stage III Esophageal Cancer and is currently ongoing. Cancer Institute and Hospital, Chinese Academy of Medical Sciences leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2024 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Not Yet Recruiting → Unknown Status
-
Nov 2022 — Jan 2024 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2021 — Nov 2022 [monthly]
Not Yet Recruiting PHASE3
▶ Show 1 earlier version
-
Nov 2018 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Peking University Cancer Hospital & Institute
- Sun Yat-sen University
- Tianjin Medical University Cancer Institute and Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.